sndx-6352
Showing 1 - 3 of 3
Unresectable Intrahepatic Cholangiocarcinoma Trial in Baltimore (Durvalumab, SNDX-6352)
Active, not recruiting
- Unresectable Intrahepatic Cholangiocarcinoma
- Durvalumab
- SNDX-6352
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Jan 10, 2023
Chronic Graft-versus-host-disease Trial in United States (SNDX-6352)
Active, not recruiting
- Chronic Graft-versus-host-disease
- SNDX-6352
-
Birmingham, Alabama
- +10 more
Aug 18, 2022